The University of California, Los Angeles School of Medicine — known as the David Geffen School of Medicine at UCLA — is an accredited medical school located in Los Angeles, California, USA. The School was renamed in 2001 in honor of media mogul David Geffen who donated $200 million in unrestricted funds.
The David Geffen School of Medicine at UCLA accepts applications for summer academic enrichment programs. These programs include the Premedical/Predental Enrichment Program (PREP), Summer Medical Dental Education Program (SMDEP), and the Re-Application Post baccalaureate Program (RAP).
The following is the list of scholars from David Geffen School of Medicine who currently serve as editors for one or more SciTechnol journals.
The following is the list of scholars from David Geffen School of Medicine who published one or more articles in SciTechnol journals.
The following is the list of articles by scholars from David Geffen School of Medicine that are published in SciTechnol journals.
Microvascular effect after the application of cell therapy with a concentrate of hematopoietic stem cells in patients with peripheral arterial disease with non-critical limb ischemia and diabetesResearch Article: J Regen Med 2020, 9:3
Lauro Fabián Amador Medina1 *, Blanca Olivia Murillo Ortíz1 , Luis Carlos Padierna García2 , Carlos Villaseñor Mora2 , Enrique Castro Camus3 , Goretti Hernández Cardoso3 and Juan Manuel Malacara Hernández 4
Adipose Derived Stem Cell Engraftment Improves Erectile Function in a Rat Model of Cavernosal Nerve InjuryResearch Article: J Regen Med 2020, 9:3
James E. Anaissie1 , Amit G. Reddy1 , Bryant Song2 , Zahra Brabadi3 , Nora M. Haney4, Fatemeh Daneshimehr3 , Travis Chen2 , Kevin Swan2 , Kenneth J. DeLay5 , Laith Alzweri5 , Philip Kadowitz2 , Bysani Chandrasekar6,7 , Eckhard U. Alt3 , Wayne J.G. Hellstrom4 and Reza Izadpanah3
- Commentary: J Regen Med 2020, 9:3
Clinical outcomes and safety of a combined autologous bone marrow concentrate intraosseous and intraarticular injection for knee osteoarthritis at 12 monthsResearch Article: J Regen Med 2020, 9:3
M. Sheinkop1*, M. Langhenry1, D. Curran-Everett3, and T. T. Sand4
Comparison of Vitronectin and Fibronectin as Substrates during the Culture of Human Embryonic Stem CellsShort Communication: J Regen Med 2020, 9:3